Critical Care Research and Practice / 2012 / Article / Tab 1

Clinical Study

The Antibiotic Resistance Profiles of Bacterial Strains Isolated from Patients with Hospital-Acquired Bloodstream and Urinary Tract Infections

Table 1

Antimicrobial resistance profiles of hospital-acquired bacterial isolates from clinical blood specimens.

Antimicrobial agents MicroorganismsTotal n (%)
CoNS* 
n (%)
. 
n (%)
. 
n (%)
Aceinetobacter  spp.n (%)  spp.
n (%)
. 
n (%)
. 
n (%)

Ciprofloxacin22 (48.9)18 (47.4)6 (42.9)5 (45.5)1 (11.1)2 (40)2 (40)56 (43.4)
Ceftazidime18 (40)15 (39.5)6 (42.9)6 (54.5)3 (33.3)3 (60)3 (60)54 (41.9)
Amikacin20 (44.4)6 (15.8)6 (42.9)6 (54.5)0 (0)3 (60)3 (60)44 (34.1)
Imipenem16 (35.6)6 (15.8)6 (42.9)6 (54.5)2 (22.2)4 (80)4 (80)44 (34.1)
Clindamycin28 (62.2)19 (50)6 (42.9)6 (54.5)2 (22.2)3 (60)4 (80)68 (52.7)
Vancomycin2 (4.4)NA*NANANA0 (0)NA2 (1.6)
Cephalothin22 (48.9)16 (42.1)9 (64.3)9 (81.8)3 (33.3)2 (40)3 (60)64 (49.6)
Ampicillin34 (75.6)24 (63.2)7 (50)7 (63.6)4 (44.4)5 (100)5 (100)86 (66.7)
Cotrimoxazole26 (57.8)19 (50)12 (85.7)7 (63.6)1 (11.1)5 (100)5 (100)75 (58.1)
Cefoxitin26 (57.8)17 (44.7)8 (47.1)6 (54.5)2 (22.2)4 (80)4 (80)67 (51.9)
Oxacillin28 (62.2)NANANANA2 (40)NA30 (23.3)
Erythromycin17 (37.8)13 (34.2)6 (42.9)4 (36.4)1 (11.1)3 (60)4 (80)48 (37.2)
Tetracycline23 (51.1)24 (63.2)9 (64.3)5 (45.5)6 (66.6)4 (80)5 (100)76 (58.9)
Penicillin41 (91.1)22 (58)11 (78.6)7 (63.6)4 (44.4)5 (100)5 (100)95 (73.6)
Gentamicin16 (35.6)6 (15.8)4 (28.6)7 (63.6)2 (22.2)4 (80)2 (40)41 (31.8)

Total45 (34.8)38 (29.4)14 (11)11 (8.5)9 (7)5 (3.9)5 (3.9)127 (98.5)

CoNS*: Coagulase-negative Staphylococci.
NA*: Not applicable.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.